{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:28:16Z","timestamp":1793500096721,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.medj.2022.03.009","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T10:40:58Z","timestamp":1650019258000},"page":"309-324.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2"],"prefix":"10.1016","volume":"3","author":[{"given":"Tamarand L.","family":"Darling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoling","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Whitener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"VanBlargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci L.","family":"Bricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayan","family":"Bamunuarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuljeet","family":"Seehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Halfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayda M.","family":"Elbashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin K.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa B.","family":"Thackray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-8224","authenticated-orcid":false,"given":"Adrianus C.M.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2022.03.009_bib1","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.15585\/mmwr.mm7037e3","article-title":"Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalization - five veterans affairs medical Centers, United States, February 1-August 6, 2021","volume":"70","author":"Bajema","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.medj.2022.03.009_bib2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.15585\/mmwr.mm7037e2","article-title":"Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent Care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance - Nine States, June-August 2021","volume":"70","author":"Grannis","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.medj.2022.03.009_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.15585\/mmwr.mm7034e2","article-title":"Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults - United States, March-July 2021","volume":"70","author":"Tenforde","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.medj.2022.03.009_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.15585\/mmwr.mm7034e4","article-title":"Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (Delta) variant Predominance - eight U.S. Locations, December 2020-August 2021","volume":"70","author":"Fowlkes","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.medj.2022.03.009_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.15585\/mmwr.mm7034e3","volume":"70","author":"Nanduri","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.medj.2022.03.009_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2022.03.009_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.03.009_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.03.009_bib9","doi-asserted-by":"crossref","first-page":"105038","DOI":"10.1016\/j.meegid.2021.105038","article-title":"Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2","volume":"95","author":"Laiton-Donato","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.medj.2022.03.009_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-021-04005-0","article-title":"High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape","volume":"600","author":"Schmidt","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.03.009_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1021\/acs.jcim.1c01243","article-title":"The R346K mutation in the Mu variant of SARS-CoV-2 alters the interactions with monoclonal antibodies from class 2: a free energy of perturbation study","volume":"62","author":"Fratev","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.medj.2022.03.009_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.medj.2021.12.005","article-title":"Durability of immune responses to the BNT162b2 mRNA vaccine","volume":"3","author":"Suthar","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.medj.2022.03.009_bib13","article-title":"Neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies in individuals with and without previous history of infection","author":"Tada","year":"2021","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.medj.2022.03.009_bib14","article-title":"Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera","author":"Uriu","year":"2021","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.medj.2022.03.009_bib15","article-title":"Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines","author":"Wang","year":"2021","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.medj.2022.03.009_bib16","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1002\/jmv.27247","article-title":"A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine","volume":"93","author":"Messali","year":"2021","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.medj.2022.03.009_bib17","article-title":"The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera","author":"Rathnasinghe","year":"2021","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.medj.2022.03.009_bib18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy","volume":"369","author":"Gu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.medj.2022.03.009_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-021-03720-y","article-title":"In\u00a0vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains","volume":"596","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.03.009_bib20","article-title":"Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.medj.2022.03.009_bib21","doi-asserted-by":"crossref","first-page":"109400","DOI":"10.1016\/j.celrep.2021.109400","article-title":"A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2022.03.009_bib22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.immuni.2021.08.013","article-title":"A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants","volume":"54","author":"Schmitz","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.medj.2022.03.009_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.03.009_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02395-21","article-title":"Neutralizing monoclonal antibodies that target the spike receptor binding domain confer Fc receptor-independent protection against SARS-CoV-2 infection in Syrian hamsters","volume":"12","author":"Su","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.medj.2022.03.009_bib25","doi-asserted-by":"crossref","first-page":"100405","DOI":"10.1016\/j.xcrm.2021.100405","article-title":"Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination","volume":"2","author":"Gorman","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.medj.2022.03.009_bib26","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.10.052","article-title":"Compromised humoral functional evolution tracks with SARS-CoV-2 mortality","volume":"183","author":"Zohar","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.medj.2022.03.009_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-020-00243-x","article-title":"Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses","volume":"5","author":"Bos","year":"2020","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.medj.2022.03.009_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03681-2","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans","volume":"596","author":"Alter","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.03.009_bib29","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1-2a trial of Ad26.COV2.S covid-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2022.03.009_bib30","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jama.2021.3645","article-title":"Immunogenicity of the Ad26.COV2.S vaccine for COVID-19","volume":"325","author":"Stephenson","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.medj.2022.03.009_bib31","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.chom.2021.10.001","article-title":"Mice with diverse microbial exposure histories as a model for preclinical vaccine testing","volume":"29","author":"Fiege","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.medj.2022.03.009_bib32","article-title":"Neutralizing efficacy of vaccines against the SARS-CoV-2 Mu variant","author":"Miyakawa","year":"2021","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.medj.2022.03.009_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.03.009_bib34","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1080\/22221751.2020.1858177","article-title":"Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection","volume":"9","author":"Rosenke","year":"2020","journal-title":"Emerg Microb. Infect."},{"key":"10.1016\/j.medj.2022.03.009_bib44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","article-title":"A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies","volume":"182","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.medj.2022.03.009_bib35","doi-asserted-by":"crossref","first-page":"eabc3582","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.medj.2022.03.009_bib36","doi-asserted-by":"crossref","first-page":"eaaz6893","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process on innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.medj.2022.03.009_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.medj.2022.03.009_bib38","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.medj.2022.03.009_bib39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2022.03.009_bib40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"issue":"630","key":"10.1016\/j.medj.2022.03.009_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm3302","article-title":"Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains","volume":"14","author":"Ying","year":"2022","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.medj.2022.03.009_bib42","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.immuni.2021.08.016","article-title":"A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope","volume":"54","author":"VanBlargan","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.medj.2022.03.009_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/clinchem\/hvaa029","article-title":"Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia","volume":"66","author":"Chu","year":"2020","journal-title":"Clin. Chem."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634022001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634022001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:55:55Z","timestamp":1763002555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634022001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2666634022001374"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2022.03.009","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.29.474432","asserted-by":"object"}]},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2022.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}